Clinical Trial Update: Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study update evaluating how sirolimus and mycophenolate mofetil affect vascular function and cellular markers in renal transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rapamune (sirolimus)

Snippet

Sponsor: University Hospital Muenster | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED